Dr. Kyle Byron Womack, MD

Dr. Womack practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Womack's NPI, 1922065796, was assigned on April 27, 2006. Dr. Womack graduated from University of Texas Southwestern Medical School at Dallas in 1987. Dr. Womack holds Missouri license 2020020119.

Dr. Womack's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Womack also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Womack's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Womack is also affiliated with Missouri Baptist Medical Center. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Womack to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Womack practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Womack's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Womack is licensed in Missouri.

CMS data shows 590 Medicare services from Dr. Womack across 6 procedure codes in 2024, for 169 Medicare patients. Medicare paid $28,939 for them.

CMS counts 169 Medicare patients who saw Dr. Womack in 2024. The largest group is 75 to 84, with 81 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Womack's median patient age at 75, with 54% women.

In 2024, Dr. Womack wrote 1,054 Medicare Part D claims for 234 patients. 94% of them were for generic drugs. CMS names the drug for 1,004 of them, across 13 drugs with 11 or more claims each, at $29,451 in total drug cost. In 2023, CMS named 813 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Womack for performance year 2024, reported as part of a group. Dr. Womack accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 43 papers to Dr. Womack, published from 2010 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Alzheimer Disease, Magnetic Resonance Imaging and Cognitive Dysfunction. Dr. Womack has published most often in Alzheimers Dement. Dr. Womack's most frequent co-authors are John Hart, MD, Ramon R. Diaz-Arrastia, MD and Raymond Scott Turner, MD, PhD.

Dmand AI links Dr. Womack to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Pick Disease of the Brain and Plaque, Amyloid.

CMS Open Payments shows 10 general payments to Dr. Womack from 3 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 60% of the total. Janssen Research & Development, LLC paid the most, $895.

Dr. Womack graduated from University of Texas Southwestern Medical School at Dallas in 1987.